A phase 1 dose escalation study of the pyruvate kinase activator mitapivat (AG-348) in sickle cell disease
- Resource Type
- Article
- Authors
- Xu, Julia Z.; Conrey, Anna; Frey, Ingrid; Gwaabe, Eveline; Menapace, Laurel A.; Tumburu, Laxminath; Lundt, Maureen; Lequang, Timothy; Li, Quan; Glass, Kristen; Dunkelberger, Emily B.; Iyer, Varsha; Mangus, Heidi; Kung, Charles; Dang, Lenny; Kosinski, Penelope A.; Hawkins, Peter; Jeffries, Neal; Eaton, William A.; Lay Thein, Swee
- Source
- In Blood 10 November 2022 140(19):2053-2062
- Subject
- Clinical Trials and Observations
Red Cells, Iron, and Erythropoiesis
Sickle Cell Disease
- Language
- ISSN
- 0006-4971